Company News

BUZZ-U.S. STOCKS ON THE MOVE-Broadcom, Biogen, Bitauto, Akari Therapeutics

* Eikon search string for individual stock moves:

* The Day Ahead newsletter:

* The Morning News Call newsletter: U.S. stocks were set to open higher for the third straight day on Friday on growing optimism around trade talks between the United States and China as well as stronger-than-expected domestic retail sales.

At 9:05 a.m. ET, Dow e-minis were up 0.24% at 27,264. S&P 500 e-minis were up 0.14% at 3,016, while Nasdaq 100 e-minis were down 0.03% at 7,919.25. The top three NYSE percentage gainers premarket: ** Vince Holding Corp, up 19.2% ** Mallinckrodt, up 13.7% ** Bitauto Holdings Ltd, up 12.3% The top three NYSE percentage losers premarket: ** Sculptor Capital Management Inc, down 52.2% ** Ra Medical Systems Inc, down 7.1% ** Progressive Corp, down 3.9% The top three Nasdaq percentage gainers premarket: ** Mer Telemanagement Solutions Ltd, up 108.3% ** Fibrocell Science Inc, up 60.0% ** Senestech Inc, up 16.9% The top three Nasdaq percentage losers premarket: ** Ritter Pharmaceuticals Inc, down 72.1% ** Quotient Ltd, down 12.9% ** Ardelyx Inc, down 10.8% ** Broadcom Inc: down 1.1% premarket BUZZ-Falls after narrow revenue miss ** LightPath Technologies Inc: down 6.3% premarket BUZZ-Tariffs on Chinese goods hurt results ** Ritter Pharmaceuticals Inc: down 72.1% premarket BUZZ-Plunge as lactose intolerance therapy fails trial ** Park Hotels & Resorts Inc: up 2.6% premarket BUZZ-Set to join S&P Midcap 400 following Chesapeake Lodging buy ** Fibrocell Science Inc: up 60.0% premarket BUZZ-Shares rally after buyout deal ** Zynga Inc: down 0.5% premarket BUZZ-Shares slip on security breach incident ** Biogen Inc: down 0.6% premarket BUZZ-Shares slip as company, Eisai discontinue two more Alzheimer’s trials ** Bitauto Holdings: up 12.3% premarket BUZZ-Soars on go-private offer ** Etsy Inc: up 3.0% premarket BUZZ-Rises as Wedbush sees promise in ads and free shipping ** Akari Therapeutics: up 11.3% premarket BUZZ-At 2-week high on orphan drug designation for rare skin disease (Compiled by Ayanti Bera in Bengaluru)